Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ADVANCED MALIGNANT-MELANOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 41 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jelic, S; Babovic, N; Stamatovic, L; Kreacic, M; Matkovic, S; Popov, I
      Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study

      MEDICAL ONCOLOGY
    2. Hobohm, U
      Fever and cancer in perspective

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    3. Denny, WA
      Prodrug strategies in cancer therapy

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    4. O'Day, SJ; Boasberg, PD; Kristedja, TS; Martin, M; Wang, HJ; Fournier, P; Cabot, M; DeGregorio, MW; Gammon, G
      High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma

      CANCER
    5. Denny, WA; Wilson, WR
      Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    6. Terheyden, P; Becker, JC; Kampgen, E; Brocker, EB
      Sequential interferon-alpha 2b, interleukin-2 and fotemustine for patientswith metastatic melanoma

      MELANOMA RESEARCH
    7. Schrader, AJ
      Combined chemoimmunotherapy in metastatic melanoma - is there a need for the double?

      ANTI-CANCER DRUGS
    8. Becker, JC; Kampgen, E; Brocker, EB
      Classical chemotherapy for metastatic melanoma

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    9. Hernberg, M; Pyrhonen, S; Muhonen, T
      Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: An overview of randomized trials

      JOURNAL OF IMMUNOTHERAPY
    10. Czejka, MJ; Schueller, J; Kletzl, H; Strauch, S; Pietrzak, C
      Clinical significance of pharmacokinetic drug interactions between interferon-alpha and antineoplastic drugs

      BIODRUGS
    11. Hochster, H; Strawderman, MH; Harris, JE; Atkins, MB; Oken, M; Skeel, RT; Jubelirer, SJ; Parkinson, D
      Conventional dose melphalan is inactive in metastatic melanoma: results ofan Eastern Cooperative Oncology Group Study (E1687)

      ANTI-CANCER DRUGS
    12. O'Day, SJ; Gammon, G; Boasberg, PD; Martin, MA; Kristedja, TS; Guo, M; Stern, S; Edwards, S; Fournier, P; Weisberg, M; Cannon, M; Fawzy, NW; Johnson, TD; Essner, R; Foshag, LJ; Morton, DL
      Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    13. Lake, BG
      Coumarin metabolism, toxicity and carcinogenicity: Relevance for human risk assessment

      FOOD AND CHEMICAL TOXICOLOGY
    14. Fraker, DL
      Hyperthermic regional perfusion for melanoma and sarcoma of the limbs - Inbrief

      CURRENT PROBLEMS IN SURGERY
    15. KARP SE
      LOW-DOSE INTRAVENOUS BOLUS INTERLEUKIN-2 WITH INTERFERON-ALPHA THERAPY FOR METASTATIC MELANOMA AND RENAL-CELL CARCINOMA

      Journal of immunotherapy
    16. LEGHA SS; RING S; ETON O; BEDIKIAN A; BUZAID AC; PLAGER C; PAPADOPOULOS N
      DEVELOPMENT OF A BIOCHEMOTHERAPY REGIMEN WITH CONCURRENT ADMINISTRATION OF CISPLATIN, VINBLASTINE, DACARBAZINE, INTERFERON-ALPHA, AND INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC MELANOMA

      Journal of clinical oncology
    17. ROSENTHAL MA; GREEN M; WIERNIK P; BORDEN EC; MARSH JC; HALLER DG
      EPIRUBICIN HAS MODEST SINGLE-AGENT ACTIVITY IN HEAD AND NECK-CANCER BUT LIMITED ACTIVITY IN METASTATIC MELANOMA AND COLORECTAL-CANCER - PHASE-II STUDIES BY THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP

      American journal of clinical oncology
    18. BAFALOUKOS D; FOUNTZILAS G; SKARLOS D; PAVLIDIS N; BAKOYIANNIS C; KARVOUNIS N; KOSMIDIS P
      SUBCUTANEOUS LOW-DOSES OF INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA WITH CARBOPLATIN AND VINBLASTINE IN PATIENTS WITH ADVANCED MELANOMA

      Oncology
    19. KLEEBERG UR
      WISHFUL THINKING, UNICENTRIC EMPIRICISM AND THE EVERYDAY WORLD OF THEMEDICAL MELANOMOLOGIST

      Melanoma research
    20. KEILHOLZ U; GOEY SH; PUNT CJA; PROEBSTLE TM; SALZMANN R; SCHEIBENBOGEN C; SCHADENDORF D; LIENARD D; ENK A; DUMMER R; HANTICH B; GEUEKE AM; EGGERMONT AMM
      INTERFERON ALFA-2A AND INTERLEUKIN-2 WITH OR WITHOUT CISPLATIN IN METASTATIC MELANOMA - A RANDOMIZED TRIAL OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER MELANOMA COOPERATIVE GROUP

      Journal of clinical oncology
    21. QUAN WDY; DEAN GE; SPEARS L; SPEARS CP; GROSHEN S; MERRITT JA; MITCHELL MS
      ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC MELANOMA WITH AN ANTIIDIOTYPE VACCINE - A PHASE I II TRIAL OF I-MEL-2 PLUS SAF-M/

      Journal of clinical oncology
    22. HWU WJP; MOZDZIESZ DE
      MOLECULAR-BASIS FOR THYMIDINE MODULATION OF THE EFFICACY AND TOXICITYOF ALKYLATING-AGENTS

      Pharmacology & therapeutics
    23. WANG HK; LEE KH
      ANTITUMOR AGENTS .176. PLANT-DERIVED ANTICANCER AGENTS AND THEIR ANALOGS CURRENTLY IN CLINICAL USE OR IN CLINICAL-TRIALS

      Zhongyang yanjiuyuan. zhiwuxue huikan
    24. EVERETT SA; DENNIS MF; PATEL KB; WARDMAN P; STRATFORD MRL
      HIGH-PERFORMANCE ION CHROMATOGRAPHY APPLIED TO FREE-RADICAL MECHANISMS IN DRUG DESIGN - THE PROBLEM OF ION ANALYSIS AT HIGH IONIC STRENGTHS

      Journal of chromatography
    25. NOBLE S; GOA KL
      ALDESLEUKIN (RECOMBINANT INTERLEUKIN-2) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY IN PATIENTS WITH METASTATIC MELANOMA

      Biodrugs
    26. SIGURDARDOTTIR V; BRANDBERG Y; SULLIVAN M
      CRITERION-BASED VALIDATION OF THE EORTC QLQ-C36 IN ADVANCED MELANOMA - THE CIPS QUESTIONNAIRE AND PROXY RATERS

      Quality of life research
    27. EGGERMONT AMM
      TREATMENT OF MELANOMA IN-TRANSIT METASTASES CONFINED TO THE LIMB

      Cancer surveys
    28. YAMAMOTO M; KUSUMOTO T; ENDO K; BABA H; SAKAGUCHI Y; MAEHARA Y; SUGIMACHI K
      VASOACTING AGENTS FLAVONE ACETIC-ACID AND HYDRALAZINE GIVEN IN COMBINATION ENHANCE ANTITUMOR EFFECTS UNDER CONDITION OF HYPERTHERMIA

      Oncology
    29. LACAL PM; DATRI S; ORLANDO L; BONMASSAR E; GRAZIANI G
      IN-VITRO INACTIVATION OF HUMAN O-6-ALKYLGUANINE DNA ALKYLTRANSFERASE BY ANTITUMOR TRIAZENE COMPOUNDS

      The Journal of pharmacology and experimental therapeutics
    30. DOVEIL GC; FIERRO MT; NOVELLI M; APPINO A; BERTERO M; QUAGLINO P; BERNENGO MG
      ADJUVANT THERAPY OF STAGE IIIB MELANOMA WITH INTERFERON ALFA-2B - CLINICAL AND IMMUNOLOGICAL RELEVANCE

      Dermatology
    31. DANCEY J; STEWARD WP
      THE ROLE OF VINDESINE IN ONCOLOGY - RECOMMENDATIONS AFTER 10 YEARS EXPERIENCE

      Anti-cancer drugs
    32. KLEEBERG UR; GAWLIK C; BROCKER EB; BOEWER C; CHATELAIN RP; QUEISSER W; WESTERHAUSEN M; ROTHE B; FRIEDRICH G; EDLER L
      INTERFERON-ALPHA-2B AND FOTEMUSTINE IN PATIENTS WITH DISSEMINATED MELANOMA - A MULTICENTER PHASE-II TRIAL OF THE AIO PHASE-I PHASE-II STUDY-GROUP OF THE GERMAN-CANCER-SOCIETY

      Onkologie
    33. DEFORNI M; CHABOT GG; ARMAND JP; GOUYETTE A; KLINKALAK M; RECONDO G
      PHASE-I AND PHARMACOLOGY STUDY OF FLAVONE ACETIC-ACID ADMINISTERED 2 OR 3 TIMES WEEKLY WITHOUT ALKALINIZATION

      Cancer chemotherapy and pharmacology
    34. FIERLBECK G; SCHREINER T; RASSNER G
      COMBINATION OF HIGHLY PURIFIED HUMAN-LEUKOCYTE INTERFERON-ALPHA AND 13-CIS-RETINOIC ACID FOR THE TREATMENT OF METASTATIC MELANOMA

      Cancer immunology and immunotherapy
    35. HOLMLUND JT; KOPP WC; WILTROUT RH; LONGO DL; URBA WJ; JANIK JE; SZNOL M; CONLON KC; FENTON RG; HORNUNG R; MADARA K; SHIELDS MA; SMITH JW; SHARFMAN W; STEIS RG; EWEL C; MALSPEIS L; CREEKMORE SP
      A PHASE-I CLINICAL-TRIAL OF FLAVONE-8-ACETIC ACID IN COMBINATION WITHINTERLEUKIN-2

      Journal of the National Cancer Institute
    36. TUROWSKI RC; TRIOZZI PL
      APPLICATION OF CHEMICAL IMMUNOMODULATORS TO THE TREATMENT OF CANCER AND AIDS

      Cancer investigation
    37. VLASVELD LT; RANKIN EM
      RECOMBINANT INTERLEUKIN-2 IN CANCER - BASIC AND CLINICAL ASPECTS

      Cancer treatment reviews
    38. EVERETT SA; CANDEIAS LP; DENNY WA; WARDMAN P
      DECARBOXYLATION OF THE ANTITUMOR DRUGS FLAVONE-8-ACETIC ACID AND XANTHENONE-4-ACETIC ACID BY NITROGEN-DIOXIDE

      Anti-cancer drug design
    39. MOHLER JL; WILLIAMS BT; THOMPSON IM; MARSHALL ME
      COUMARIN (1,2-BENZOPYRONE) FOR THE TREATMENT OF PROSTATIC-CARCINOMA

      Journal of cancer research and clinical oncology
    40. SIGURDARDOTTIR V; BOLUND C; BRANDBERG Y; SULLIVAN M
      THE IMPACT OF GENERALIZED MALIGNANT-MELANOMA ON QUALITY-OF-LIFE EVALUATED BY THE EORTC QUESTIONNAIRE TECHNIQUE

      Quality of life research
    41. CARTEI G; SALA PG; SANZARI M; CESCHIA V; CLOCCHIATTI L; SIBAU A; DONA S; GIOVANNONI M; VIGEVANI E
      REDUCED LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH ADVANCED OR DISSEMINATED MELANOMA

      Journal of the American Academy of Dermatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 13:17:50